Sysmex South Africa


Our XE-2100 differential analyser is a great example of why we are global leaders in haematology. Its fluorescence flow cytometry analysis technology delivers accuracy and precision never achieved before. Because it's extremely fast, processing up to 150 samples per hour, you can deliver results more quickly and greatly enhance the productivity of your lab. That’s good news for patients, and good for your bottom line.

The accuracy and clinical utility of our instruments are renowned around the world. The XE-2100 is the first analyser with a standard 5-part differential plus NRBC count. High-quality standard parameters for red blood cells make it easier to detect and screen anaemia. And hydrodynamic focusing in the RBC/PLT channel delivers a red blood cell parameter profile and haematocrit values in line with the ICSH reference methods. This level of accuracy and versatility opens doors for more powerful clinical utility and better patient support.


Sysmex South Africa (Pty) Ltd

Fernridge Office Park, Block 1,

Randburg 2194

+27 (11) 329 94 80

Copyright © Sysmex Europe GmbH. All rights reserved.
Customize your experience

We use cookies to enable you to optimally use our Website and to improve our communication with you. We shall take your selection into account and use only the data for which you give us your consent.

* May lead to restrictions in content and in the user experience
Detail about cookies
Essential cookies
These cookies help to make our website usable by enabling basic features such as page navigation and access to secure areas of our website. Our website cannot function properly without these cookies.
Statistics cookies
By collecting information anonymously, these cookies help us to understand how visitors interact with our website. This information enables us to continually improve our platform.
Marketing cookies
are used to track visitors on websites. The intention is to show advertisements that are relevant and appealing to the individual user and are, therefore, valuable to publishers and third-party advertisers.